Natixis’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-272,598	Closed	-$2.72M	–	1108
2024 Q1	$2.72M	Buy	+272,598	New	+$2.72M	0.01%	382